Barr Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in developing, manufacturing and marketing generic and proprietary pharmaceuticals. A research-intensive pharmaceutical company, Barr is listed on the New York Stock Exchange (NYSE: BRL).